Showing results (1-10 of 119) with videos related to
Sort By:
Pageof 12
Vitamins and Hormones|February 21, 2017
Neurotrophic Factors Used to Treat Spinal Cord InjuryS I Hodgetts, A R HarveyNeuroscience|April 6, 2007
Strain-specific differences in the effects of cyclosporin A and FK506 on the survival and regeneration of axotomized retinal ganglion cells in adult ratsQ Cui, S I Hodgetts, Y Hu, et al.Handbook of Clinical Neurology|October 27, 2012
Scaffolds to promote spinal cord regenerationS Sakiyama-Elbert, P J Johnson, S I Hodgetts, et al.Scientific Reports|July 11, 2020
Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editingC Moses, S I Hodgetts, F Nugent, et al.Immunology and Cell Biology|May 31, 2001
Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5S I Hodgetts, M D GroundsJournal of Cellular and Molecular Medicine|June 18, 2002
Problems and solutions in myoblast transfer therapyG M Smythe, S I Hodgetts, M D GroundsMolecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Immunobiology and the future of myoblast transfer therapyG M Smythe, S I Hodgetts, M D GroundsJournal of Virology|March 14, 1998
Characterization of defective viral RNA produced during persistent infection of Vero cells with Murray Valley encephalitis virusM U Lancaster, S I Hodgetts, J S Mackenzie, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1995
Differential transcription efficiency of two Ig VH promoters in vitroK L Buchanan, S I Hodgetts, J Byrnes, et al.Cell Transplantation|October 19, 2000
Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cellsS I Hodgetts, M W Beilharz, A A Scalzo, et al.Pageof 12